Metabolisable pH sensitive polymersomes

US12544334B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12544334-B2
Application numberUS-201917046953-A
CountryUS
Kind codeB2
Filing dateApr 11, 2019
Priority dateApr 13, 2018
Publication dateFeb 10, 2026
Grant dateFeb 10, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application relates to pH-sensitive polymersomes. The polymersomes are capable of degradation at endosomes' mild acidic pH into resorbable materials, which also allows avoiding liposome premature degradation of the payload once internalised inside the cells. The polymersomes can thus be used in methods for the treatment or prevention of diseases.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A polymersome that comprises: (a) a protein repellent polymer; and (b) a pH sensitive biodegradable succinate polymer comprising (i) succinate monomeric units in the polymer backbone, and (ii) a pendant group with a pKa of from 6.2 to 7, wherein the pendant group comprises an imidazole moiety. 2 . The polymersome of claim 1 , wherein the protein repellent polymer is an acrylate polymer, a polypeptide, a polyester, a polyamide, a polyanhydride, a polyurethane, a polyether, a polyimine, a polyurea, a polyacetal, a polysaccharide or a polycarbonate. 3 . The polymersome of claim 2 , wherein the protein repellent polymer comprises units of formula (I) in which R p is hydrogen or methyl and A p is a group of formula (I′) in which X p is a C 1-6 alkylene group. 4 . The polymersome of claim 1 , wherein the protein repellent polymer is poly (2-(methacryloyloxy) ethyl phosphorylcholine) or poly (ethylene oxide). 5 . The polymersome of claim 1 , wherein the imidazole moiety is imidazole, methylimidazole or dimethylimidazole. 6 . The polymersome of claim 1 , wherein the pH sensitive biodegradable succinate polymer is poly[propylene 2-((2-(2-(1H-imidazol-5-yl) acetamido)-3-(tert-butoxy)-3-oxopropyl) thio) succinate]. 7 . The polymersome of claim 1 , which further comprises a drug encapsulated within the polymersome. 8 . A pharmaceutical composition comprising: a plurality of the polymersomes of claim 1 ; and one or more pharmaceutically acceptable excipients or diluents. 9 . A method that comprises administering the polymersome of claim 1 to a subject. 10 . A method that comprises: (i) administering the polymersome of claim 7 to a subject; and (ii) releasing the drug in vivo in the subject.

Assignees

Inventors

Classifications

  • Manufacture or treatment of nanostructures · CPC title

  • Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

  • A61K9/1273Primary

    Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12544334B2 cover?
The present application relates to pH-sensitive polymersomes. The polymersomes are capable of degradation at endosomes' mild acidic pH into resorbable materials, which also allows avoiding liposome premature degradation of the payload once internalised inside the cells. The polymersomes can thus be used in methods for the treatment or prevention of diseases.
Who is the assignee on this patent?
Ucl Business Ltd
What technology area does this patent fall under?
Primary CPC classification A61K9/1273. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).